United Therapeutics Corp
NASDAQ:UTHR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
United Therapeutics Corp
NASDAQ:UTHR
|
US |
|
Tata Motors Passenger Vehicles Ltd
NSE:TMPV
|
IN |
|
Create Restaurants Holdings Inc
TSE:3387
|
JP |
|
Garb Oil & Power Corp
OTC:GARB
|
US |
|
G
|
Golf & Co Group Ltd
TASE:GOLF
|
IL |
|
Eurotech SpA
MIL:ETH
|
IT |
|
P
|
Phoenix Group Holdings PLC
F:1BF
|
UK |
|
Guangdong Topstar Technology Co Ltd
SZSE:300607
|
CN |
|
Sterlite Technologies Ltd
NSE:STLTECH
|
IN |
|
Z
|
Zendesk Inc
F:0ZD
|
US |
|
Fairfax Financial Holdings Ltd
TSX:FFH
|
CA |
|
EVgo Inc
NASDAQ:EVGO
|
US |
|
VNET Group Inc
NASDAQ:VNET
|
CN |
|
C
|
Cords Cable Industries Ltd
NSE:CORDSCABLE
|
IN |
|
Pan American Silver Corp
TSX:PAAS
|
CA |
|
AirBoss of America Corp
TSX:BOS
|
CA |
|
F
|
Fulcrum Metals PLC
LSE:FMET
|
UK |
Wall Street
Price Targets
UTHR Price Targets Summary
United Therapeutics Corp
According to Wall Street analysts, the average 1-year price target for
UTHR
is 546.81 USD
with a low forecast of 427.23 USD and a high forecast of 677.25 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is UTHR's stock price target?
Price Target
546.81
USD
According to Wall Street analysts, the average 1-year price target for
UTHR
is 546.81 USD
with a low forecast of 427.23 USD and a high forecast of 677.25 USD.
What is United Therapeutics Corp's Revenue forecast?
Projected CAGR
11%
For the last 14 years the
compound annual growth rate for
United Therapeutics Corp's revenue is
11%.
The projected
CAGR
for the next 3 years is
11%.
What is United Therapeutics Corp's Operating Income forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
United Therapeutics Corp's operating income is
9%.
The projected
CAGR
for the next 3 years is
13%.
What is United Therapeutics Corp's Net Income forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
United Therapeutics Corp's net income is
10%.
The projected
CAGR
for the next 3 years is
7%.
